# A Smoking Cessation Intervention for Yale Dining Employees

> **NCT02562521** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 25 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **BEHAVIORAL:** Contingency management
- **DRUG:** Nicotine replacement therapy
- **DRUG:** Varenicline
- **BEHAVIORAL:** Additional behavioral support

## Key facts

- **NCT ID:** NCT02562521
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562521, "A Smoking Cessation Intervention for Yale Dining Employees". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT02562521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*